The successful candidate will be mentored by an experienced investigator with a track record of developing novel antibody technologies and therapeutics. This hire will engineer antibodies and other proteins through rational design and molecular evolution technologies to enhance their existing properties or endow them with brand new capabilities. A major interest is to make currently intractable targets druggable - pursuit of the 'high-hanging fruit'.

Requirements:

The successful candidate will have a Ph. D. in molecular biology, protein chemistry, structural biology or a related discipline. Creative individuals with a passion for science and capable of independent work in a collaborative environment are particularly encouraged to apply. Well-qualified individuals will have one or more first author research publications in high quality journals in protein/antibody engineering or a related field. Experience in protein/antibody engineering from rational design, through generation of mutants, to the expression, purification and characterization of mutant proteins is desirable. Expertise with molecular evolution technologies such as yeast or phage display is a plus. Excellent oral and written communication skills are needed.

For more information about Paul Carter's lab at Genentech, please visit:

For more information about our Postdoctoral Program at Genentech, please visit:

Roche is an Equal Opportunity Employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status.